Regeneron/Sanofi stops late-stage Libtayo study early after improvement in survival in NSCLC patients
August 05 2021 - 6:23AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to Apr 2024